These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 20015887)

  • 1. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
    Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
    Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
    Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
    Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of quantitative flow cytometry immunophenotypic analysis of CD5 expression in small B-cell neoplasms.
    Challagundla P; Jorgensen JL; Kanagal-Shamanna R; Gurevich I; Pierson DM; Ferrajoli A; Reyes SR; Medeiros LJ; Miranda RN
    Arch Pathol Lab Med; 2014 Jul; 138(7):903-9. PubMed ID: 24978916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinicopathologic features and differential diagnosis of splenic B-cell marginal zone lymphoma involving bone marrow].
    Sun Q; Zhang PH; Liu EB; Liu W; Li ZQ; Yang QY; Fang LH; Sun FJ; Chen HS; Qiu LG
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):234-8. PubMed ID: 23928529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
    Patel N; Durkin L; Bodo J; Hsi ED
    Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. t(1;14) and t(11;18) in the differential diagnosis of Waldenström's macroglobulinemia.
    Ye H; Chuang SS; Dogan A; Isaacson PG; Du MQ
    Mod Pathol; 2004 Sep; 17(9):1150-4. PubMed ID: 15143341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of CD5-positive splenic marginal zone lymphoma with leukemic manifestation ; clinical, flow cytometry, and histopathological findings of 11 cases.
    Kojima M; Sato E; Oshimi K; Murase T; Koike T; Tsunoda S; Matsumoto T; Marutsuka K; Ogiya D; Moriuchi M; Tokunaka M; Yara Kikuti Y; Kikuchi T; Nakamura N; Ando K
    J Clin Exp Hematop; 2010; 50(2):107-12. PubMed ID: 21123968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and clinical considerations in concomitant bone marrow involvement by plasma cell myeloma and chronic lymphocytic leukemia/monoclonal B-cell lymphocytosis: a series of 15 cases and review of literature.
    Alley CL; Wang E; Dunphy CH; Gong JZ; Lu CM; Boswell EL; Burchette J; Lagoo AS
    Arch Pathol Lab Med; 2013 Apr; 137(4):503-17. PubMed ID: 23544940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Single-center Experience in Splenic Diffuse Red Pulp Lymphoma Diagnosis.
    Julhakyan HL; Al-Radi LS; Moiseeva TN; Danishyan KI; Kovrigina AM; Glebova SM; Lugovskaya SA; Dvirnik VN; Khvastunova AN; Yakutik IA; Savchenko VG
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S166-9. PubMed ID: 27131623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.
    Dronca RS; Jevremovic D; Hanson CA; Rabe KG; Shanafelt TD; Morice WG; Call TG; Kay NE; Collins CS; Schwager SM; Slager SL; Zent CS
    Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S35-41. PubMed ID: 20568273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of blood and bone marrow examination in the diagnosis of mature lymphoid neoplasms in patients presenting with isolated splenomegaly.
    Sreedharanunni S; Sachdeva MU; Malhotra P; Ahluwalia J; Naseem S; Prakash G; Khadwal A; Sharma P; Kumar N; Varma N; Varma S; Das R
    Hematology; 2015 Oct; 20(9):530-7. PubMed ID: 25760312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic marginal zone lymphoma: hydra with many heads?
    Arcaini L; Paulli M
    Haematologica; 2010 Apr; 95(4):534-7. PubMed ID: 20378575
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathologic characteristics of bone marrow for 
CD5 positive small B cell lymphoma].
    Peng S; Zhu F; You S; Gong M; Wen Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 41(4):374-9. PubMed ID: 27241147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cytogenetic approach to the diagnosis of splenic lymphoma: a case report of blastoid mantle cell lymphoma.
    Björck E; Landgren O; Schoumans J; Christensson B; Björkholm M; MacDonald AP; Nordenskjöld M
    Leuk Lymphoma; 2003 Jul; 44(7):1229-34. PubMed ID: 12916877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of splenic marginal zone lymphoma from B lymphoproliferative disorders by flow cytometry].
    Hu Y; Chen Y; Wang LH; Chen X; Fang F; Liu SQ; Wu XQ; Zhu P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):349-56. PubMed ID: 24763004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.
    Hamadeh F; MacNamara SP; Aguilera NS; Swerdlow SH; Cook JR
    Mod Pathol; 2015 Apr; 28(4):564-74. PubMed ID: 25216226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic features of lymphoplasmacytic lymphoma].
    Liu EB; Zhang PH; Li ZQ; Sun Q; Yang QY; Fang LH; Sun FJ; Qiu LG
    Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):308-12. PubMed ID: 20654153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
    Salido M; Baró C; Oscier D; Stamatopoulos K; Dierlamm J; Matutes E; Traverse-Glehen A; Berger F; Felman P; Thieblemont C; Gesk S; Athanasiadou A; Davis Z; Gardiner A; Milla F; Ferrer A; Mollejo M; Calasanz MJ; Florensa L; Espinet B; Luño E; Wlodarska I; Verhoef G; García-Granero M; Salar A; Papadaki T; Serrano S; Piris MA; Solé F
    Blood; 2010 Sep; 116(9):1479-88. PubMed ID: 20479288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features of CD5-positive splenic marginal zone lymphoma.
    Li Y; Wang G; Liu E; Zhang D; Zhang Y; Jian X; Zhao W; Li W
    J Clin Pathol; 2024 May; 77(6):421-425. PubMed ID: 36922019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.